A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.
Our Science Surgery series answers your cancer science questions. Read our answer to Patrick's question.
The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse.
CRT pioneer fund, Cancer Research UK and NCI collaborate to boost research against the ‘undruggable’ RAS
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute.
In this post we’ll be exploring the gene editing technology CRISPR by answering some of the most common questions that pop up.
As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates.
For the first time, scientists have used the gene-editing tool CRISPR to tweak the DNA of specialised brain stem cells, which could help us understand certain brain...
Scientists have uncovered how tumours are able to grow despite significant damage to the structure and number of their chromosomes - the storage units of DNA.